Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
05/26/2026 - 17:37
PHARMANUTRA
CS disponibilità del verbale di Assemblea ordinaria || PR availability of the shareholders' meeting minutes
05/13/2026 - 17:10
PHARMANUTRA
Filing on Interim Management Report as at March 31st 2026
05/11/2026 - 17:35
PHARMANUTRA
THE BoD APPROVES THE INTERIM MANAGEMENT REPORT AS OF MARCH 31ST 2026
05/11/2026 - 17:35
PHARMANUTRA
IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026
04/30/2026 - 15:47
PHARMANUTRA
Summary report of voting results
04/27/2026 - 18:37
PHARMANUTRA
Resolutions of the Ordinary Shareholders' Meeting and of the BoD of April 27, 2026
04/27/2026 - 18:35
PHARMANUTRA
Delibere dell'Assemblea Ordinaria degli Azionisti e del Consiglio di Amministrazione del 27 aprile 2026
04/06/2026 - 21:34
PHARMANUTRA
CS disponibilità documentazione assemblea | PR availability of documentation
04/06/2026 - 19:22
PHARMANUTRA
PR | PUBLICATION OF THE LISTS SUBMITTED FOR THE APPOINTMENT OF THE BoD
04/06/2026 - 19:21
PHARMANUTRA
CS | Deposito Liste nomina CdA
04/03/2026 - 21:51
PHARMANUTRA
CS disponibilità documenti per Assemblea | PR availability of documentation for Shareholder's Meeting
03/27/2026 - 18:10
PHARMANUTRA
PHARMANUTRA - PHN - DEPOSITO DOCUMENTAZIONE PER ASSEMBLEA DEGLI AZIONISTI
03/27/2026 - 13:30
PHARMANUTRA
CS disponibilità della documentazione assembleare / PR availability of shareholders’ meeting documentation
03/17/2026 - 18:38
PHARMANUTRA
NOTICE OF CALLING OF THE ORDINARY SHAREHOLDERS’ MEETING
03/17/2026 - 18:36
PHARMANUTRA
Avviso di convocazione Assemblea ordinaria degli azionisti
03/17/2026 - 17:43
PHARMANUTRA
PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025
03/17/2026 - 17:41
PHARMANUTRA
PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025
03/03/2026 - 07:48
PHARMANUTRA
PHARMANUTRA - PHN - PARTNERSHIP SIGNED FOR THE DISTRIBUTION OF SIDERAL PRODUCTS IN FRANCE AND SWITZERLAND
03/03/2026 - 07:45
PHARMANUTRA
PHARMANUTRA - PHN - SIGLATA PARTNERSHIP PER LA DISTRIBUZIONE DEI PRODOTTI SIDERAL IN FRANCIA E SVIZZERA
02/23/2026 - 18:01
PHARMANUTRA
PHARMANUTRA - PHN - GUIDELINES OF THE BOD TO SHAREHOLDERS ON THE FUTURE SIZE AND COMPOSITION OF THE NEW BOD - APPOINTMENT OF THE INVESTOR RELATIONS DIRECTOR
02/23/2026 - 17:58
PHARMANUTRA
PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR
01/12/2026 - 17:52
PHARMANUTRA
PHARMANUTRA PHN - PRELIMINARY REVENUES 2025
01/12/2026 - 17:49
PHARMANUTRA
PHARMANUTRA PHN - RICAVI PRELIMINARI 2025
12/16/2025 - 12:50
PHARMANUTRA
PHARMANUTRA - Corporate events calendar 2026

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are